- Singular Genomics Systems press release ( NASDAQ: OMIC ): Q3 GAAP EPS of -$0.33 beats by $0.10 .
-
Cash, cash equivalents and short-term investments, excluding restricted cash, as of September 30, 2022 totaled $263.8 million.
- Operating expenses for the third quarter of 2022 totaled $24.7 million compared to $17.5 million for the third quarter of 2021.
- Operating expenses included non-cash stock-based compensation expense of $3.4 million in the third quarter of 2022 and $2.9 million in the third quarter of 2021.
For further details see:
Singular Genomics Systems GAAP EPS of -$0.33 beats by $0.10